Sivik Global Healthcare LLC Has $3.17 Million Stake in Humana Inc. (NYSE:HUM)

Sivik Global Healthcare LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 33.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,000 shares of the insurance provider's stock after purchasing an additional 2,500 shares during the quarter. Sivik Global Healthcare LLC's holdings in Humana were worth $3,167,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Creative Financial Designs Inc. ADV increased its position in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock worth $27,000 after acquiring an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its stake in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock valued at $28,000 after purchasing an additional 39 shares during the period. Atwood & Palmer Inc. purchased a new stake in shares of Humana in the third quarter valued at $29,000. Ashton Thomas Securities LLC acquired a new stake in shares of Humana in the third quarter worth $31,000. Finally, Your Advocates Ltd. LLP grew its holdings in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after buying an additional 45 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Sanford C. Bernstein upgraded Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective for the company in a research report on Tuesday, October 8th. Bank of America raised shares of Humana from an "underperform" rating to a "neutral" rating and increased their price target for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Jefferies Financial Group downgraded shares of Humana from a "buy" rating to a "hold" rating and lowered their price objective for the company from $519.00 to $253.00 in a research report on Monday, October 7th. Leerink Partners downgraded shares of Humana from an "outperform" rating to a "market perform" rating and cut their target price for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Finally, Wells Fargo & Company lowered their price target on shares of Humana from $387.00 to $290.00 and set an "overweight" rating on the stock in a report on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $315.86.

Humana Stock Performance

Shares of HUM stock traded down $6.45 during trading hours on Thursday, reaching $282.97. 2,048,984 shares of the company's stock were exchanged, compared to its average volume of 1,875,087. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $34.07 billion, a P/E ratio of 25.67, a P/E/G ratio of 2.21 and a beta of 0.52. The business has a fifty day moving average price of $284.64 and a 200-day moving average price of $332.14.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analysts' expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Analysts predict that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.25%. Humana's dividend payout ratio (DPR) is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.